Who owns Biofermin?
Biofermin is owned by Taisho Pharmaceutical (Japan).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: Taisho Pharmaceutical: History, Taisho Pharmaceutical Co., Ltd. Last checked .
Key facts
- Current owner
- Taisho Pharmaceutical Holdings Co., Ltd. reported
- Owner HQ
- 🇯🇵 Japan, Tokyo
- Origin
- 🇯🇵 Japan
- Category
- Consumer health › Over-the-counter medicine › Digestive health
- Last verified
- · 1 sources
About Biofermin
Intestinal regulator brand. Taisho made Biofermin Pharmaceutical, the maker of Biofermin, a consolidated subsidiary in 2008, and describes the brand as the top name in intestinal medicine in Japan. The range includes lactic acid bacteria tablets, a laxative based on magnesium oxide and anti-diarrhoea products, plus versions for dogs and cats.
Ownership timeline of Biofermin
- Current owner Taisho Pharmaceutical [1] reported
Where Biofermin sits in Taisho Pharmaceutical
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Taisho Pharmaceutical ownership tree →
See the full Taisho Pharmaceutical brand portfolio (7) →
Other brands owned by Taisho Pharmaceutical
Taisho Pharmaceutical controls 7 brands on Brandtree, 6 of them in consumer health.
Also in consumer health
- Dafalgan
- Efferalgan
- Hapacol
- Naron (1960)
- Pabron (1927)
Other brands in digestive health, and who owns them
The 23 brands in digestive health on Brandtree belong to 16 owners. The largest is Bayer, with 2.
| Brand | Owner | Owner based in |
|---|---|---|
| Alka-Seltzer | Bayer | 🇩🇪 Germany |
| Daiichi Sankyo Stomach Medicine | Daiichi Sankyo Healthcare | 🇯🇵 Japan |
| Kaopectate | Genomma Lab | 🇲🇽 Mexico |
| Epocler | Hypera | 🇧🇷 Brazil |
| Entrostop | Kalbe Farma | 🇮🇩 Indonesia |
| Metamucil | Procter & Gamble | 🇺🇸 United States |
| Buscolysin | Sopharma | 🇧🇬 Bulgaria |
| Oracal | Birzeit Pharmaceutical | 🇵🇸 Palestine |
About the owner: Taisho Pharmaceutical
Taisho Pharmaceutical is a privately held company headquartered in Tokyo, Japan, founded in 1912. Brandtree records 7 brands under its control.
Japanese pharmaceutical and over-the-counter health company, founded in 1912 and based in Toshima-ku, Tokyo. Its shares were delisted from the stock exchange on 9 April 2024, so it is now unlisted. Outside Japan it bought Bristol-Myers Squibb's Asian OTC trademarks in 2009 and took control of Vietnam's Duoc Hau Giang (DHG) and France's UPSA in 2019; Taisho also sells some brands in Japan under licence from other owners (for example Vicks and Claritin), which are not listed here.
Taisho Pharmaceutical: full profile, brands and acquisition history →
🇯🇵 Biofermin and other Japanese brands
Brandtree records a controlling owner for 437 brands that began in Japan. 21 of them (5%) are now controlled by a company headquartered in another country; Biofermin is not one of them.
- Air Salonpas — Hisamitsu Pharmaceutical 🇯🇵
- Ammeltz — Kobayashi Pharmaceutical 🇯🇵
- Daiichi Sankyo Stomach Medicine — Daiichi Sankyo Healthcare 🇯🇵
- Jelly Monster — Okamoto Industries 🇯🇵
- "K" Line — K Line 🇯🇵
- ABEMA — CyberAgent 🇯🇵
Frequently asked questions
Who is the parent company of Biofermin?
The parent company of Biofermin is Taisho Pharmaceutical, a privately held company headquartered in Japan.
Is Biofermin Japanese?
Yes. Biofermin originated in Japan and its owner, Taisho Pharmaceutical, is also headquartered in Japan.
Is Biofermin still owned by Taisho Pharmaceutical?
Yes. As of 4 October 2026, Biofermin is still owned by Taisho Pharmaceutical. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Taisho Pharmaceutical: History — Taisho Pharmaceutical Co., Ltd., Official document; retrieved 4 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.